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Volume 57, Number 5S Abstracts 19Sbetween index surgery and presenting complaints varied
from 6 weeks to 12 years. Presentation included discharg-
ing sinus, Pseudo aneurysm, or non-speciﬁc symptoms like
erythema, fever and pain. Nine patients showed increased
18F-FDG uptake within the graft and in surrounding soft
tissue, 2 showed increased up take in surrounding soft
tissue alone and in one patient no uptake was seen within
the graft/soft tissue. FDG PET CT had a sensitivity of
100%, Speciﬁcity of 66.6%, a Positive predictive value of
87.5% and a Negative predictive value of 100%. Klebsiella,
pseudomonas, E coli and Morganella Morgagni were the
common organisms isolated.
Conclusions: 18F-FDG PET/CT is a reliable non-
invasive imaging modality for the diagnosis of vascular
graft-related infection. The precise anatomic localization
of increased 18F-FDG uptake provided by PET/CT
enables accurate differentiation between graft and soft-
tissue infection. It is the future Gold Standard test.
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One-Year Results of the Multilayer Flow Modulator
Stent in the Management of Thoracoabdominal
Aortic Aneurysms
Sherif Sultan1, Niamh Hynes2. 1Vascular & Endovascular
Surgery, Western Vascular Institute, Galway, Ireland;
2Galway Clinic, Galway, Ireland
Objectives: We report early results using multi-layer
ﬂow modulator (MFM) stent technology for aortic repair.
Methods: Out of 243 cases implanted worldwide we
present the ﬁrst 55 cases that were implanted under indica-
tion for use. All were done on compassionate basis, in 11
countries.
Primary Endpoints are Freedom from Rupture and
Aneurysm-related Death.
Results: They were 31 Thoraco-abdominal (8 Type I,
3 Type II, 9 Type III, and 11 Type IV), 7 arch, 3 abdom-
inal and 8 suprarenal aneurysms and 6 type B dissections.
Mean age of 64.5 years; mean aneurysm diameter was
6.04cm+/1.66cm and mean length was 11.58cm+/
7.62cm. The mean number of side branches covered
was 3.7 per case for a total number of 202branches.
Mean stents per case was 1.96.
Aneurysm related survival 93.7% (SE+/4.44%) at one
year. No rupture occurred. Four cases of consumptive coa-
gulopathy were observed, two of which resulted in death
from hemorrhagic cerebrovascular stroke and one of which
resulted in death from a gastrointestinal bleed.
Technical success was 98.2%. One-year all-cause
survival was 84.8% (SE+/6.25%). There was no para-
plegia No peri-operative visceral or renal insult occurred.
At 12 months all of the 202 side branches were patent.
There were no stent fractures.
One-year intervention free survival was 92.4% (SE+/
5.09%) At six months the mean rate of sac volume
increase was 0.36% per month, resulting in a mean volume
increase of 2.14%. At twelve months the rate of increase
had slowed to 0.28% per month, resulting in a total average
increase in sac volume of 3.26%. The ratio of thrombus tototal volume stayed almost constant over the 12 months at
0.48, while the ratio of ﬂow to total volume fell from 0.21
to 0.12 at 12 months.
Conclusions: Increasing sac size did not herald
rupture. MFM implantation instigates a process of aortic
remodeling involving initial thrombus deposition, which
slowed between six and twelve months. The MFM was
not associated with loss of native side branches.
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Endovascular Treatment of Abdominal Aortic
Aneurysms Should Not Be Denied to High-Surgical-
Risk Patients
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Cristiano M. Schmitt2. 1Red Cross University Hospital.
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Objectives: To analyze the initial and long-term
results of endovascular aneurysm repair (EVAR) in high-
surgical-risk patients (i.e., age $ 80 years, serum creatinine
level $ 3 mg/dL, severe pulmonary dysfunction, severe
cardiac dysfunction) with favorable anatomy (ie, proximal
neck length of at least 15mm, proximal neck angulation
< 60, absence of thrombus in the proximal neck).
Methods: From April 2002 to November 2012, 80
consecutive high-surgical-risk patients (65 men; mean age
74 years, range 54-91 years) with an abdominal aortic
aneurysm (AAA; mean diameter 66.6 mm) who were
treated electively using a bifurcated aortic endograft (39
Excluder, 40 Zenith, 1 Endurant) were entered in
a prospective registry. Fifty-ﬁve (68.7%) patients were
classiﬁed ASA III and 25 (31.3%) were ASA IV. High-
surgical-risk status was corroborated using the validated
Customized Probability Index score. All patients used sta-
tins and betablockers in the perioperative period. Primary
end points were operative mortality and long-term survival;
secondary end points were the frequency of reintervention,
evolution of the aneurysm sac, rates of primary and
secondary patency and rupture.
Results: ThemeanCustomized Probability Index score
in our patients was 12.1. Operative mortality was 1.25% (1/
80). There were 5 endoleaks and 2 endograft limb occlu-
sions. Four patients required reintervention during the
mean follow-up of 35.9 months. Survival at 3 years was
91.25%. Primary and secondary patency rates at 3 years
were 97.5% and 100%, respectively. There were no ruptures.
Conclusions: Our initial and long-term results with
EVAR in high-risk patients were satisfactory and appear
to justify this approach in this patient population. The
most important factor for improvement of the short and
long-term results of aortic endografts is respect of anatomic
feasibility conditions.
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